-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Aerovate Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2020 to 2024.
- Aerovate Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$23.7M, a 107% decline year-over-year.
- Aerovate Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$71.2M, a 25.4% decline from 2023.
- Aerovate Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$56.8M, a 45.1% decline from 2022.
- Aerovate Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$39.1M, a 42.8% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)